FUNDING ANNOUNCEMENT Winners of the 2024 Proof of Principle Grant Competition Christine Bear Senior Scientist, Molecular Medicine Comparison of SickKids CFTR Potentiator to Ensifentrine in Ameliorating COPD in In-Vitro and In-Vivo Models Jayne Danska Senior Scientist, Genetics & Genome Biology [...]
FUNDING ANNOUNCEMENT SickKids Researcher Receives Commercialization Grant for Development of COPD Treatment Dr. Christine Bear, Senior Scientist and Co-Director of the Cystic Fibrosis Centre at The Hospital for Sick Children (SickKids) and Professor at The University of Toronto, has been awarded $325,125 to support the commercialization of a novel treatment [...]
FUNDING ANNOUNCEMENT Radiant Biotherapeutics Secures $35 Million to Advance Multabody™ Therapeutics Industry Partnerships & Commercialization (IP&C) is excited to share that Radiant Biotherapeutics has closed a $35 million USD series A financing co-led by the Bill & Melinda Gates Foundation and Amplitude Ventures. Radiant Biotherapeutics [...]
General Inquiries
Email: ipc.requests@sickkids.ca
Peter Gilgan Centre for Research and Learning
686 Bay Street, Toronto
Ontario, Canada
M5G 0A4
SickKids Industry Partnerships & Commercialization operates on the traditional land of the Huron-Wendat and Petun First Nations, the Seneca, and the Mississaugas of the Credit River.
© 1999 – 2024 The Hospital for Sick Children (SickKids) – All Rights Reserved.
